News

Vietnam's Ministry of Health grants three-year market licence to Russian-made pembrolizumab drug and 13 other vaccines and biologics, reinforcing regulatory rigor and supply protocols in the oncology sector.

Evotec has secured a $5 million milestone from Bristol Myers Squibb after the FDA accepted an IND for their jointly-developed molecular glue degrader, marking progress in their protein degradation R&D alliance.

Dr Richard Pazdur, an expert in oncology regulation, is the new leader of the FDA’s Center for Drug Evaluation and Research (CDER), signaling intensified regulatory reforms and accelerated drug approvals in the US pharmaceutical sector.

Shilpa Pharma Lifesciences, a leading Indian CDMO, secures EcoVadis Gold Medal for exemplary sustainability, bolstering its global B2B reputation.

Cosmo Pharmaceuticals secures a higher S&P Global ESG rating and EcoVadis Bronze Medal for its Italian manufacturing plant, advancing transparency and supplier sustainability across its European pharma operations.

Pharmaceutical manufacturers are calling for the FDA to extend its PreCheck program to existing facilities to accelerate domestic production and address drug shortages.

Venus Remedies has obtained new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam, expanding its critical care exports in Southeast Asia.

New data shows high barrier pharmaceutical packaging films market in Europe and globally is growing strongly, driven by stringent regulatory demands and rising drug safety standards.

Regulatory demands and drug quality standards are fueling robust market expansion for high barrier pharmaceutical blister packaging films.

Sichuan Biokin Pharmaceutical pursues a $432 million Hong Kong listing to expand R&D and global manufacturing capabilities, with strategic backing from major investors.